HISTOLOGY and HISTOPATHOLOGY (Non-Edited

Total Page:16

File Type:pdf, Size:1020Kb

HISTOLOGY and HISTOPATHOLOGY (Non-Edited ONLINE FIRST This is a provisional PDF only. Copyedited and fully formatted versión will Be made available at final puBliCation ISSN: 0213-3911 e-ISSN: 1699-5848 HISTOPATHOLOGY Submit your article to this Journal (http://www.hh.um.es/Instructions.htmmanuscript)) Membrane TraffickingAND and Exocytosis are Upregulated in Port Wine Stain Blood Vessels Authors: Rong Yin, Shawn J. Rice, Jinwei Wang, Lin Gao, Joseph Tsai, Radean T. Anvari, Fang Zhou, Xin Liu, Gang Wang, Yuxin Tang, Martin C. Mihm, Jr., Chandra P. Belani, Dong bao Chen, J. Stuart Nelson and Wenbin Tan (non-edited DOI: 10.14670/HH-18-051 Article type: ORIGINAL ARTICLE HISTOLOGYAccepted: 2018-10-10 Epub ahead of print: 2018-10-10 This artiCle has Been peer reviewed and puBlished immdediately upon acCeptanCe. ArtiCles in “Histology and Histopathology” are listed in PuBmed. Pre-print author´s version 1 Membrane Trafficking and Exocytosis are Upregulated in Port Wine Stain 2 Blood Vessels 3 Running Title: membrane trafficking and exocytosis in PWS 4 Rong Yin1,2,9, Shawn J. Rice3, Jinwei Wang1,8, Lin Gao5, Joseph Tsai1, Radean T. Anvari1, Fang 5 Zhou1,8, Xin Liu3, Gang Wang5, Yuxin Tang8, Martin C. Mihm, Jr.6, Chandra P. Belani3,4, Dong- 6 bao Chen10, J. Stuart Nelson1,7 and Wenbin Tan1,2* 7 1Department of Surgery, Beckman Laser Institute and Medical Clinic, University of California, 8 Irvine, Irvine, California 92617, USA 9 2Department of Cell Biology and Anatomy, University of South Carolina School of Medicine, 10 Columbia, South Carolina 29209, USA 11 3Penn State Cancer Institute, Hershey, PA 17033HISTOPATHOLOGY 12 4Department of Medicine, Penn State College of Medicine,manuscript) Hershey, PA 17033 13 5Department of Dermatology,AND Xijing Hospital, Xi'an, 710032, China. 14 6Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, 15 Massachusetts 02115, USA 16 7Department of Biomedical Engineering, University of California, Irvine, Irvine, California 17 92617, USA (non-edited 18 8Department of Urology, the Xiangya 3rd Hospital, Xiangya School of Medicine, Central South 19 University, Changsha, Hunan 412000, China HISTOLOGY20 9Department of Dermatology, the Second Hospital of Shanxi Medical University, Taiyuan 21 030001, China 1 22 10Department of Obstetrics and Gynecology, University of California, Irvine, Irvine, California 23 92617, USA 24 Correspondence: Wenbin Tan, Department of Cell Biology and Anatomy, University of South 25 Carolina School of Medicine, Columbia, South Carolina 29209, USA; Department of Surgery, 26 Beckman Laser Institute and Medical Clinic, University of California, Irvine, Irvine, California 27 92617, USA 28 Email: [email protected] or [email protected] Phone: 803-216-3816 Fax: 803-216- 29 3846 30 Conflict of Interest: Disclosure: None Declared 31 Disclaimer Any views expressed here represent personal opinion and do not necessarily reflect 32 those of the United States Department of Health and Human Services or the federal government. HISTOPATHOLOGY 33 Prior Publication: None of the material in this manuscriptmanuscript) has been published or is under 34 consideration for publication elsewhere, including the Internet. 35 Funding statement: This workAND was supported by grants from the National Institutes of Health 36 (AR063766 and AR073172 to WT, HL70562 to DBC, AR47551 and AR59244 to JSN), the 37 Department of Defense/CDMRP (W81XWH1810096 to WT) and National Natural Science 38 Foundation of China (non-edited(81571432 to YT). 39 Acknowledgments: Institutional support was provided by the Arnold and Mabel Beckman 40 Foundation and the David and Lucile Packard Foundation. We greatly appreciate the Sue & Bill HISTOLOGY41 Gross Stem Cell Research Center at the University of California, Irvine, for their assistance with 42 the histology image acquisition process experiments. 43 Words: 2404; References: 34; Figures: 3; Table: 1 2 44 Abstract: 211 words 45 HISTOPATHOLOGY manuscript) AND (non-edited HISTOLOGY 3 46 ABSTRACT 47 Introduction: Port wine stain (PWS) is characterized as a progressive dilatation of immature 48 venule-like vasculatures which result from differentiation-impaired endothelial cells. In this 49 study, we aimed to identify the major biological pathways accounting for the pathogenesis of 50 PWS. 51 Methods: Sequential windowed acquisition of all theoretical fragment ion mass spectra 52 (SWATH-MS) was used to identify differentially expressed proteins in PWS lesions, followed 53 by confirmative studies with immunohistochemistry, immunoblot and transmission electron 54 microscopy (TEM). 55 Results: 107 out of 299 identified proteins showed differential expressions in PWS lesions as 56 compared to normal skin, mainly involvingHISTOPATHOLOGY the functions of biosynthesis, membrane trafficking, 57 cytoskeleton and cell adhesion/migration. The confirmativemanuscript) studies showed that expressions of 58 membrane trafficking/exocytosisAND related proteins such as VAT1, IQGAP1, HSC70, clathrin, 59 perlecan, spectrin α1 and GDIR1 were significantly increased in PWS blood vessels as compared 60 to normal ones; while collagen subtypes 6A1 and 6A3 were decreased in PWS skin. Furthermore, 61 TEM studies showed there is a significant upregulation of extracellular vesicle exocytosis from 62 PWS blood vessels as(non-edited compared to control. 63 Conclusions: The biological process of membrane trafficking and exocytosis is enhanced in 64 PWS blood vessels. Our results imply that the extracellular vesicles released by lesional HISTOLOGY65 endothelial cells may act as potential intercellular signaling mediators to contribute to the 66 pathogenesis of PWS. 67 4 68 Key words: Port wine stain, vascular malformations, endothelial cells, extracellular vesicle, 69 exocytosis, SWATH-MS 70 71 Introduction 72 Port wine stain (PWS) is a congenital vascular malformation resulting from differentiation- 73 impaired endothelial cells (ECs) in human skin with a progressive dilatation of immature venule- 74 like vasculatures (Tan et al., 2017). The prevalence is estimated at 3-5 children per 1,000 live 75 births (Pratt, 1953, Jacobs and Walton, 1976). PWS initially appears as flat red macules in 76 childhood; lesions tend to darken progressively to purple with soft tissue hypertrophy and, by 77 middle age, they often become raised as a HISTOPATHOLOGYresult of the development of vascular nodules which 78 are susceptible to spontaneous bleeding or hemorrhagemanuscript) (Lever and Schaumburg-Lever, 1990, 79 Geronemus and Ashinoff, 1991). PWS is a significant clinical problem that results in loss of self- 80 esteem since most malformationsAND occur on the face (Kalick, 1978, Heller et al., 1985, Malm and 81 Carlberg, 1988). The pulsed dye laser (PDL) is the treatment of choice for PWS but the regrowth 82 of pathologic blood vessels post-PDL treatment is a major clinical barrier that needs to be 83 overcome (Tan et al., 2012, Gao et al., 2014). The pathogenesis of PWS remains incompletely 84 understood. Recent (non-editedstudies have suggested that the sporadic somatic mutation of guanine 85 nucleotide-binding protein, G alpha subunit q (gnaq) (c.548G>A), is linked to PWS (Shirley et 86 al., 2013, Lian et al., 2014). The gnaq (c.548G>A) is primarily present in PWS blood vessels HISTOLOGY87 (Couto et al., 2016, Tan, Nadora , et al., 2016). In addition, PWS have sustained activation of 88 mitogen-activated protein kinases in the infantile stage and, particularly, activation of PKCα and 89 PI3K pathways in hypertrophic and nodular lesions (Tan et al., 2014, Yin et al., 2017). We have 5 90 recently found that PWS blood vessels are immature capillary vasculatures with aberrant 91 expressions of stem cell markers CD133 and CD166, venous marker EphB1 and arterial marker 92 Ephrin B2 (EfnB2). The disruption of normal EC-EC interactions by co-existence of EphB1 and 93 EfnB2 contributes to progressive dilatation of PWS vasculatures (Tan et al., 2017). 94 In this study, we aimed to identify differentially expressed (DE) proteins in PWS lesions as 95 compared to normal skin using a proteomics approach, namely sequential windowed acquisition 96 of all theoretical fragment ion mass spectra (SWATH-MS). We then performed a further 97 investigation to determine their expression patterns and cellular localizations in PWS 98 hypertrophic lesions and nodules as compared to control. We found that PWS blood vessels have 99 increased expressions of cell membrane trafficking/exocytosis related molecules and that the 100 exocytosis of extracellular vesicles (EVs) isHISTOPATHOLOGY enhanced in PWS blood vessels. 101 manuscript) AND (non-edited HISTOLOGY 6 102 Materials and Methods 103 104 Patients and Tissue Samples 105 This study was approved by the Institutional Review Board at the University of California, Irvine 106 (UCI) (#2013-9396) and Xijing Hospital. A total of 21 PWS biopsies and 6 adjacent normal skin 107 samples were obtained from 13 subjects and de-identified for this study. The clinical 108 characteristics of the subjects and biopsy samples have been described previously (Tan et al., 109 2014, Yin et al., 2017). 110 111 SWATH-MS HISTOPATHOLOGY 112 The formalin-fixed paraffin-embedded (FFPE) sectionsmanuscript) were used for SWATH-MS. There were 113 two groups of specimens, e.g., control (n=3) and PWS (n=6). The protocols of protein extraction 114 from FFPE sections and peptideAND library preparation have been previously reported (Ostasiewicz 115 et al., 2010). All samples were duplicated during the mass spectrometry studies. Mass spectra
Recommended publications
  • Annexin A2 Flop-Out Mediates the Non-Vesicular Release of Damps/Alarmins from C6 Glioma Cells Induced by Serum-Free Conditions
    cells Article Annexin A2 Flop-Out Mediates the Non-Vesicular Release of DAMPs/Alarmins from C6 Glioma Cells Induced by Serum-Free Conditions Hayato Matsunaga 1,2,† , Sebok Kumar Halder 1,3,† and Hiroshi Ueda 1,4,* 1 Pharmacology and Therapeutic Innovation, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8521, Japan; [email protected] (H.M.); [email protected] (S.K.H.) 2 Department of Medical Pharmacology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan 3 San Diego Biomedical Research Institute, San Diego, CA 92121, USA 4 Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan * Correspondence: [email protected]; Tel.: +81-75-753-4536 † These authors contributed equally to this work. Abstract: Prothymosin alpha (ProTα) and S100A13 are released from C6 glioma cells under serum- free conditions via membrane tethering mediated by Ca2+-dependent interactions between S100A13 and p40 synaptotagmin-1 (Syt-1), which is further associated with plasma membrane syntaxin-1 (Stx-1). The present study revealed that S100A13 interacted with annexin A2 (ANXA2) and this interaction was enhanced by Ca2+ and p40 Syt-1. Amlexanox (Amx) inhibited the association between S100A13 and ANXA2 in C6 glioma cells cultured under serum-free conditions in the in situ proximity ligation assay. In the absence of Amx, however, the serum-free stress results in a flop-out of ANXA2 Citation: Matsunaga, H.; Halder, through the membrane, without the extracellular release. The intracellular delivery of anti-ANXA2 S.K.; Ueda, H. Annexin A2 Flop-Out antibody blocked the serum-free stress-induced cellular loss of ProTα, S100A13, and Syt-1.
    [Show full text]
  • Table 1 Gene Name Increased Or Decreased in LTD
    Table_1 gene_name increased or decreased in LTD protein_id description keep_supernatant keep_pellet comparison sample hit_annotation_methodpvalue fdr hit hit_annotation 2010300C02RIK increased E9Q3M9 Protein 2010300C02Rik OS=Mus musculus GN=2010300C02Rik PE=1 SV=1 TRUE TRUE NMDA - control pellet fdrtool 0,074667 0,584087 FALSE trend 2310035C23RIK|KIAA1468increased A0A087WSS1|E9QM90|Q148V7|Q148V7-2 Protein 2310035C23Rik OS=Mus musculus GN=2310035C23Rik PE=1 SV=1|Protein 2310035C23Rik OS=Mus musculusTRUE GN=2310035C23Rik PE=1 SV=2|LisH FALSE domain NMDAand HEAT - control repeat-containing protein KIAA1468 supernatant OS=Mus musculus GN=Kiaa1468 fdrtoolPE=1 SV=1|Isoform 0,080056 2 of 0,589077LisH domain FALSEand HEAT trend repeat-containing protein KIAA1468 OS=Mus musculus GN=Kiaa1468 ABR increased E9PUE7|Q5SSL4|Q5SSL4-2|Q5SSL4-3|Q5SSL4-4 Active breakpoint cluster region-related protein OS=Mus musculus GN=Abr PE=1 SV=1|Isoform 2 of Active breakpointTRUE cluster region-related protein TRUE OS=Mus musculus NMDA GN=Abr|Isoform - control 3 of Active breakpoint supernatant cluster region-related protein OS=Mus fdrtool musculus 0,08128 GN=Abr|Isoform 0,592743 4 of Active FALSE breakpoint trend cluster region-related protein OS=Mus musculus GN=Abr ADAM22 increased D3YUP9|Q9R1V6|Q9R1V6-10|Q9R1V6-11|Q9R1V6-12|Q9R1V6-13|Q9R1V6-14|Q9R1V6-15|Q9R1V6-17|Q9R1V6-4|Q9R1V6-5|Q9R1V6-6|Q9R1V6-7|Q9R1V6-8Disintegrin and metalloproteinase domain-containing protein 22 OS=Mus musculus GN=Adam22 PE=1 SV=1|DisintegrinFALSE and metalloproteinase domain-containing TRUE
    [Show full text]
  • A Single-Cell Transcriptional Atlas Identifies Extensive Heterogeneity in the Cellular Composition of Tendons
    bioRxiv preprint doi: https://doi.org/10.1101/801266; this version posted October 10, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. A single-cell transcriptional atlas identifies extensive heterogeneity in the cellular composition of tendons Jacob B Swanson1, Andrea J De Micheli2, Nathaniel P Disser1, Leandro M Martinez1, Nicholas R Walker1,3, Benjamin D Cosgrove2, Christopher L Mendias1,3,* 1Hospital for Special Surgery, New York, NY, USA 2Meining School of Biomedical Engineering, Cornell University, Ithaca, NY, USA 3Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY, USA *Corresponding Author Christopher Mendias, PhD Hospital for Special Surgery 535 E 70th St New York, NY 10021 USA +1 212-606-1785 [email protected] Keywords: tenocyte; tendon fibroblast; pericyte; single-cell RNA sequencing bioRxiv preprint doi: https://doi.org/10.1101/801266; this version posted October 10, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Tendon is a dense, hypocellular connective tissue that transmits forces between muscles and bones. Cellular heterogeneity is increasingly recognized as an important factor in the biological basis of tissue homeostasis and disease, but little is known about the diversity of cells that populate tendon. Our objective was to explore the heterogeneity of cells in mouse Achilles tendons using single-cell RNA sequencing. We identified 13 unique cell types in tendons, including 4 previously undescribed populations of fibroblasts.
    [Show full text]
  • KLF2 Induced
    UvA-DARE (Digital Academic Repository) The transcription factor KLF2 in vascular biology Boon, R.A. Publication date 2008 Link to publication Citation for published version (APA): Boon, R. A. (2008). The transcription factor KLF2 in vascular biology. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:23 Sep 2021 Supplementary data: Genes induced by KLF2 Dekker et al. LocusLink Accession Gene Sequence Description Fold p-value ID number symbol change (FDR) 6654 AK022099 SOS1 cDNA FLJ12037 fis, clone HEMBB1001921. 100.00 5.9E-09 56999 AF086069 ADAMTS9 full length insert cDNA clone YZ35C05. 100.00 1.2E-09 6672 AF085934 SP100 full length insert cDNA clone YR57D07. 100.00 6.7E-13 9031 AF132602 BAZ1B Williams Syndrome critical region WS25 mRNA, partial sequence.
    [Show full text]
  • An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Netwo
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis Sriram Devanathan Washington University School of Medicine in St. Louis Timothy Whitehead Washington University School of Medicine in St. Louis George G. Schweitzer Washington University School of Medicine in St. Louis Nicole Fettig Washington University School of Medicine in St. Louis Attila Kovacs Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Devanathan, Sriram; Whitehead, Timothy; Schweitzer, George G.; Fettig, Nicole; Kovacs, Attila; Korach, Kenneth S.; Finck, Brian N.; and Shoghi, Kooresh I., ,"An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis." PLoS One.9,7. e101900. (2014). https://digitalcommons.wustl.edu/open_access_pubs/3326 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Sriram Devanathan, Timothy Whitehead, George G. Schweitzer, Nicole Fettig, Attila Kovacs, Kenneth S. Korach, Brian N. Finck, and Kooresh I. Shoghi This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/3326 An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Network Analysis Sriram Devanathan1, Timothy Whitehead1, George G. Schweitzer2, Nicole Fettig1, Attila Kovacs3, Kenneth S.
    [Show full text]
  • Human Periprostatic Adipose Tissue: Secretome from Patients With
    CANCER GENOMICS & PROTEOMICS 16 : 29-58 (2019) doi:10.21873/cgp.20110 Human Periprostatic Adipose Tissue: Secretome from Patients With Prostate Cancer or Benign Prostate Hyperplasia PAULA ALEJANDRA SACCA 1, OSVALDO NÉSTOR MAZZA 2, CARLOS SCORTICATI 2, GONZALO VITAGLIANO 3, GABRIEL CASAS 4 and JUAN CARLOS CALVO 1,5 1Institute of Biology and Experimental Medicine (IBYME), CONICET, Buenos Aires, Argentina; 2Department of Urology, School of Medicine, University of Buenos Aires, Clínical Hospital “José de San Martín”, Buenos Aires, Argentina; 3Department of Urology, Deutsches Hospital, Buenos Aires, Argentina; 4Department of Pathology, Deutsches Hospital, Buenos Aires, Argentina; 5Department of Biological Chemistry, School of Exact and Natural Sciences, University of Buenos Aires, Buenos Aires, Argentina Abstract. Background/Aim: Periprostatic adipose tissue Prostate cancer (PCa) is the second most common cancer in (PPAT) directs tumour behaviour. Microenvironment secretome men worldwide. While most men have indolent disease, provides information related to its biology. This study was which can be treated properly, the problem consists in performed to identify secreted proteins by PPAT, from both reliably distinguishing between indolent and aggressive prostate cancer and benign prostate hyperplasia (BPH) disease. Evidence shows that the microenvironment affects patients. Patients and Methods: Liquid chromatography-mass tumour behavior. spectrometry-based proteomic analysis was performed in Adipose tissue microenvironment is now known to direct PPAT-conditioned media (CM) from patients with prostate tumour growth, invasion and metastases (1, 2). Adipose cancer (CMs-T) (stage T3: CM-T3, stage T2: CM-T2) or tissue is adjacent to the prostate gland and the site of benign disease (CM-BPH). Results: The highest number and invasion of PCa.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Annexin A7 Is Required for ESCRT III-Mediated Plasma Membrane Repair
    Annexin A7 is required for ESCRT III-mediated plasma membrane repair Sønder, Stine Lauritzen; Boye, Theresa Louise; Tölle, Regine; Dengjel, Jörn; Maeda, Kenji; Jäättelä, Marja; Simonsen, Adam Cohen; Jaiswal, Jyoti K.; Nylandsted, Jesper Published in: Scientific Reports DOI: 10.1038/s41598-019-43143-4 Publication date: 2019 Document version Publisher's PDF, also known as Version of record Document license: CC BY Citation for published version (APA): Sønder, S. L., Boye, T. L., Tölle, R., Dengjel, J., Maeda, K., Jäättelä, M., ... Nylandsted, J. (2019). Annexin A7 is required for ESCRT III-mediated plasma membrane repair. Scientific Reports, 9(1), [6726]. https://doi.org/10.1038/s41598-019-43143-4 Download date: 09. apr.. 2020 www.nature.com/scientificreports OPEN Annexin A7 is required for ESCRT III-mediated plasma membrane repair Received: 16 November 2018 Stine Lauritzen Sønder1, Theresa Louise Boye1, Regine Tölle2,3, Jörn Dengjel 2,3, Accepted: 15 April 2019 Kenji Maeda1, Marja Jäättelä 1,4, Adam Cohen Simonsen 5, Jyoti K. Jaiswal 6,7 & Published: xx xx xxxx Jesper Nylandsted 1,4 The plasma membrane of eukaryotic cells forms the essential barrier to the extracellular environment, and thus plasma membrane disruptions pose a fatal threat to cells. Here, using invasive breast cancer cells we show that the Ca2+ - and phospholipid-binding protein annexin A7 is part of the plasma membrane repair response by enabling assembly of the endosomal sorting complex required for transport (ESCRT) III. Following injury to the plasma membrane and Ca2+ fux into the cytoplasm, annexin A7 forms a complex with apoptosis linked gene-2 (ALG-2) to facilitate proper recruitment and binding of ALG-2 and ALG-2-interacting protein X (ALIX) to the damaged membrane.
    [Show full text]
  • Annexin A1 Is a New Functional Linker Between Actin Filaments and Phagosomes During Phagocytosis
    578 Research Article Annexin A1 is a new functional linker between actin filaments and phagosomes during phagocytosis Devang M. Patel1, Syed Furquan Ahmad1, Dieter G. Weiss1, Volker Gerke2 and Sergei A. Kuznetsov1,* 1Institute of Biological Sciences, Cell Biology and Biosystems Technology, University of Rostock, Albert-Einstein Straße 3, Rostock 18059, Germany 2Institute of Medical Biochemistry, Centre for Molecular Biology of Inflammation, University of Münster, Von-Esmarch-Straße 56, Münster 48149, Germany *Author for correspondence ([email protected]) Accepted 19 October 2010 Journal of Cell Science 124, 578-588 © 2011. Published by The Company of Biologists Ltd doi:10.1242/jcs.076208 Summary Remodelling of the actin cytoskeleton plays a key role in particle internalisation and the phagosome maturation processes. Actin- binding proteins (ABPs) are the main players in actin remodelling but the precise role of these proteins in phagocytosis needs to be clarified. Annexins, a group of ABPs, are known to be present on phagosomes. Here, we identified annexin A1 as a factor that binds to isolated latex bead phagosomes (LBPs) in the presence of Ca2+ and facilitates the F-actin–LBP interaction in vitro. In macrophages the association of endogenous annexin A1 with LBP membranes was strongly correlated with the spatial and temporal accumulation of F-actin at the LBP. Annexin A1 was found on phagocytic cups and around early phagosomes, where the F-actin was prominently concentrated. After uptake was completed, annexin A1, along with F-actin, dissociated from the nascent LBP surface. At later stages of phagocytosis annexin A1 transiently concentrated only around those LBPs that showed transient F-actin accumulation (‘actin flashing’).
    [Show full text]
  • IL21R Expressing CD14+CD16+ Monocytes Expand in Multiple
    Plasma Cell Disorders SUPPLEMENTARY APPENDIX IL21R expressing CD14 +CD16 + monocytes expand in multiple myeloma patients leading to increased osteoclasts Marina Bolzoni, 1 Domenica Ronchetti, 2,3 Paola Storti, 1,4 Gaetano Donofrio, 5 Valentina Marchica, 1,4 Federica Costa, 1 Luca Agnelli, 2,3 Denise Toscani, 1 Rosanna Vescovini, 1 Katia Todoerti, 6 Sabrina Bonomini, 7 Gabriella Sammarelli, 1,7 Andrea Vecchi, 8 Daniela Guasco, 1 Fabrizio Accardi, 1,7 Benedetta Dalla Palma, 1,7 Barbara Gamberi, 9 Carlo Ferrari, 8 Antonino Neri, 2,3 Franco Aversa 1,4,7 and Nicola Giuliani 1,4,7 1Myeloma Unit, Dept. of Medicine and Surgery, University of Parma; 2Dept. of Oncology and Hemato-Oncology, University of Milan; 3Hematology Unit, “Fondazione IRCCS Ca’ Granda”, Ospedale Maggiore Policlinico, Milan; 4CoreLab, University Hospital of Parma; 5Dept. of Medical-Veterinary Science, University of Parma; 6Laboratory of Pre-clinical and Translational Research, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture; 7Hematology and BMT Center, University Hospital of Parma; 8Infectious Disease Unit, University Hospital of Parma and 9“Dip. Oncologico e Tecnologie Avanzate”, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy ©2017 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol. 2016.153841 Received: August 5, 2016. Accepted: December 23, 2016. Pre-published: January 5, 2017. Correspondence: [email protected] SUPPLEMENTAL METHODS Immunophenotype of BM CD14+ in patients with monoclonal gammopathies. Briefly, 100 μl of total BM aspirate was incubated in the dark with anti-human HLA-DR-PE (clone L243; BD), anti-human CD14-PerCP-Cy 5.5, anti-human CD16-PE-Cy7 (clone B73.1; BD) and anti-human CD45-APC-H 7 (clone 2D1; BD) for 20 min.
    [Show full text]
  • Annexin A2 Depletion Delays EGFR Endocytic Trafficking Via Cofilin
    Oncogene (2014) 33, 2610–2619 & 2014 Macmillan Publishers Limited All rights reserved 0950-9232/14 www.nature.com/onc ORIGINAL ARTICLE Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation M de Graauw1, L Cao2,5, L Winkel3,5, MHAM van Miltenburg4,SEleDe´ve´ dec1, M Klop1,KYan2, C Pont1, V-M Rogkoti1, A Tijsma1, A Chaudhuri1, R Lalai1, L Price1, F Verbeek2 and B van de Water1 Enhanced epidermal growth factor receptor (EGFR) activity has been strongly linked to breast cancer progression and mediators of EGFR endocytosis may well be involved. We developed a semi-automated high-content fluorescence microscopy-based EGFR endocytosis screen to identify proteins that mediate EGFR endocytosis in human HBL100 breast cancer cells. Knockdown of 172 individual endocytosis and actin-regulatory genes with small interfering RNAs led to the identification of 14 genes of which the contribution to EGFR endocytosis in breast cancer is until now poorly defined, including DNAJC6, GDI2, FGD6, HAX1, NECAP2 and AnxA2. We show that depletion of the actin and endocytosis regulatory protein annexin A2 (AnxA2) in a panel of four triple negative breast cancer (TNBC) cell lines affected EGFR endocytosis. Depletion of AnxA2 in the aggressive and highly metastatic MDA-MB-231 TNBC cell line resulted in the inhibition of EGFR transport beyond the early endosomes. This inhibition coincided with enhanced epidermal growth factor (EGF)-induced cell migration and downstream signaling via c-Jun N-terminal kinase (JNK) and Akt. Moreover, AnxA2 knockdown increased lung metastasis formation in mice. The effect of AnxA2 knockdown on EGFR endocytosis in MDA-MB-231 was related to dephosphorylation/activation of the actin-severing protein cofilin, as re-expression of an inactive S3E- cofilin mutant, but not an active S3A-cofilin mutant, re-established EGFR endocytosis to control levels.
    [Show full text]
  • Serum Albumin OS=Homo Sapiens
    Protein Name Cluster of Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 (P14136) Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 Cluster of Isoform 3 of Plectin OS=Homo sapiens GN=PLEC (Q15149-3) Cluster of Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 (P68871) Vimentin OS=Homo sapiens GN=VIM PE=1 SV=4 Cluster of Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 (Q13509) Cluster of Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 (P60709) Cluster of Tubulin alpha-1B chain OS=Homo sapiens GN=TUBA1B PE=1 SV=1 (P68363) Cluster of Isoform 2 of Spectrin alpha chain, non-erythrocytic 1 OS=Homo sapiens GN=SPTAN1 (Q13813-2) Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 Cluster of Spectrin beta chain, non-erythrocytic 1 OS=Homo sapiens GN=SPTBN1 PE=1 SV=2 (Q01082) Cluster of Pyruvate kinase isozymes M1/M2 OS=Homo sapiens GN=PKM PE=1 SV=4 (P14618) Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 Clathrin heavy chain 1 OS=Homo sapiens GN=CLTC PE=1 SV=5 Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens GN=DYNC1H1 PE=1 SV=5 Cluster of ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide OS=Homo sapiens GN=ATP1A2 PE=3 SV=1 (B1AKY9) Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 Dihydropyrimidinase-related protein 2 OS=Homo sapiens GN=DPYSL2 PE=1 SV=1 Cluster of Alpha-actinin-1 OS=Homo sapiens GN=ACTN1 PE=1 SV=2 (P12814) 60 kDa heat shock protein, mitochondrial OS=Homo
    [Show full text]